澳門:下周一起由港台地區入境人士須接受14天醫學觀察及嚴格自我健康管理
澳門特區新型冠狀病毒感染應變協調中心公布,應香港和台灣地區的疫情變化,衛生局根《傳染病防治法》規定作出公告,自周一(21日)零時起,有香港或台灣地區旅居史的入境或已入境人士,須接受集中隔離醫學觀察直至離開當地14天,並須在其後進行嚴格自我健康管理直至離開當地21天。
嚴格自我健康管理期間健康碼會轉為黃碼以及不得經澳門往內地,且須在結束集中隔離醫學觀察的第1、2、4、7天接受新冠病毒核酸檢測及遵守其他防疫措施。若在指定日期不接受檢測,健康碼會被鎖定為紅碼直至取得1次核酸檢測陰性結果。有關措施適用於所有離開香港或台灣地區不足21天的入境或已入境人士。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.